Robert Benezra
Director/Board Member chez ANGIOGENEX, INC.
Profil
Robert Benezra was the founder of AngioGenex, Inc. which was founded in 1999, where he held the titles of President, Chief Executive Officer & Director from 2014 to 2019.
He is currently a Director at AngioGenex, Inc. and a Professor at Weill Cornell Graduate School of Medical Sciences.
Dr. Benezra's former position was as a Member at Memorial Sloan Kettering Cancer Center.
He received a doctorate degree from The Trustees of Columbia University in The City of New York.
Postes actifs de Robert Benezra
Sociétés | Poste | Début |
---|---|---|
ANGIOGENEX, INC. | Director/Board Member | - |
Weill Cornell Graduate School of Medical Sciences | Corporate Officer/Principal | - |
Anciens postes connus de Robert Benezra
Sociétés | Poste | Fin |
---|---|---|
ANGIOGENEX, INC. | Chief Executive Officer | 12/09/2019 |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formation de Robert Benezra
The Trustees of Columbia University in The City of New York | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Health Services |
AngioGenex, Inc.
AngioGenex, Inc. Pharmaceuticals: MajorHealth Technology AngioGenex, Inc. operates as a biopharmaceutical company, which engages in developing and commercializing novel platform of anti-proliferative drugs for the treatment of cancer and macular degeneration. The company was founded by Michael M. Strage and Robert Benezra in March 1999 and is headquartered in New York, NY. | Health Technology |